OTC:NPHC | Free Cash Flow | NUTRA PHARMA CORP

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2011-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$327,791.00
2025-12-31-$219,818.00$0.00-$219,818.00
2025-03-31-$405,006.00$26,052.00-$431,058.00
2024-12-31-$178,210.00
2024-03-31-$171,199.00
2023-12-31-$186,229.00
2023-03-31-$92,775.00
2022-12-31-$54,032.00$0.00-$54,032.00-1.67%
2022-03-31-$258,234.00$57,993.00-$316,227.00-6.31%
2021-12-31-$233,680.00$4,275.00-$237,955.00-10.97%
2021-03-31-$594,333.00$9,950.00-$604,283.00
2020-12-31-$352,823.00
2020-03-31-$215,555.00
2019-12-31-$308,721.00
2019-03-31-$91,504.00
2018-12-31-$136,047.00
2018-03-31-$348,314.00
2017-12-31-$226,387.00
2017-03-31-$371,484.00
2016-12-31-$388,348.00$2,470.00-$390,818.00
2016-03-31-$265,734.00
2015-12-31-$190,382.00$0.00-$190,382.00-28.16%
2015-03-31-$116,974.00$718.00-$117,692.00
2014-12-31-$57,402.00$1,381.00-$58,783.00
2014-03-31-$90,542.00
2013-12-31-$114,414.00
2013-03-31-$64,075.00$0.00-$64,075.00
2012-12-31-$151,697.00
2012-03-31-$198,082.00$0.00-$198,082.00
2011-12-31$24,518.00$2,388.00$22,130.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$1.16M$26,052.00-$1.19M
2024-12-31-$423,959.00
2023-12-31-$550,036.00
2022-12-31-$762,432.00$57,993.00-$820,425.00-10.03%
2021-12-31-$1.74M$39,043.00-$1.78M
2020-12-31-$878,086.00$5,905.00-$883,991.00
2019-12-31-$743,659.00
2018-12-31-$999,949.00
2017-12-31-$1.14M$9,113.00-$1.15M
2016-12-31-$1.36M$3,382.00-$1.36M
2015-12-31-$1.02M$718.00-$1.02M
2014-12-31-$148,129.00$21,550.00-$169,679.00
2013-12-31-$531,038.00
2012-12-31-$721,242.00$0.00-$721,242.00
2011-12-31-$1.89M$1,360.00-$1.89M